Medtronic Management
Management criteria checks 2/4
Medtronic's CEO is Geoff Martha, appointed in Apr 2020, has a tenure of 5.25 years. total yearly compensation is $20.08M, comprised of 6.7% salary and 93.3% bonuses, including company stock and options. directly owns 0.007% of the company’s shares, worth $7.70M. The average tenure of the management team and the board of directors is 3.8 years and 6.3 years respectively.
Key information
Geoff Martha
Chief executive officer
US$20.1m
Total compensation
| CEO salary percentage | 6.72% |
| CEO tenure | 5.3yrs |
| CEO ownership | 0.007% |
| Management average tenure | 3.8yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Medtronic's (NYSE:MDT) Returns On Capital Are Heading Higher
Jul 07
Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap
Jun 28A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jun 16Medtronic (NYSE:MDT) Will Pay A Larger Dividend Than Last Year At $0.71
May 30Medtronic: One Of The Best Times To Buy
Apr 21Is Now An Opportune Moment To Examine Medtronic plc (NYSE:MDT)?
Apr 14Medtronic: A Great Business, But With Low Growth
Mar 27Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
Mar 20
Medtronic Stock: A Compelling Buy for Value and Income Investors as Robotics, Innovation Catalysts Ignite Upside to $105+
Strengths and Competitive Advantages:Diverse Product Portfolio: Medtronic operates across four key segments—Cardiovascular, Medical-Surgical, Neuroscience, and Diabetes—providing revenue stability andMedtronic (NYSE:MDT) Has More To Do To Multiply In Value Going Forward
Feb 17Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Feb 15Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock
Feb 07We Think Medtronic (NYSE:MDT) Can Stay On Top Of Its Debt
Jan 20Medtronic: A Dividend Aristocrat That's Poised To Pop
Jan 06Investors Appear Satisfied With Medtronic plc's (NYSE:MDT) Prospects
Jan 06Medtronic Stock Is Still A Great "Buy"
Dec 26Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Dec 03Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Nov 19Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns
Nov 08Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 31Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?
Oct 13Medtronic: Undervalued Dividend Aristocrat With High Margins
Oct 10An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued
Sep 30Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks
Sep 16Medtronic: An Undervalued Stock With Durable Competitive Advantages
Sep 16Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05Medtronic: Is The Company Back?
Aug 26Medtronic: Still A Buy Before Earnings
Aug 17Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Apr 25 2025 | n/a | n/a | US$5b |
| Jan 24 2025 | n/a | n/a | US$4b |
| Oct 25 2024 | n/a | n/a | US$4b |
| Jul 26 2024 | n/a | n/a | US$4b |
| Apr 26 2024 | US$20m | US$1m | US$4b |
| Jan 26 2024 | n/a | n/a | US$4b |
| Oct 27 2023 | n/a | n/a | US$4b |
| Jul 28 2023 | n/a | n/a | US$4b |
| Apr 28 2023 | US$15m | US$1m | US$4b |
| Jan 27 2023 | n/a | n/a | US$4b |
| Oct 28 2022 | n/a | n/a | US$4b |
| Jul 29 2022 | n/a | n/a | US$5b |
| Apr 29 2022 | n/a | n/a | US$5b |
| Jan 28 2022 | n/a | n/a | US$5b |
| Oct 29 2021 | n/a | n/a | US$5b |
| Jul 30 2021 | n/a | n/a | US$4b |
| Apr 30 2021 | US$18m | US$1m | US$4b |
| Jan 29 2021 | n/a | n/a | US$3b |
| Oct 30 2020 | n/a | n/a | US$4b |
| Jul 31 2020 | n/a | n/a | US$4b |
| Apr 24 2020 | US$6m | US$905k | US$5b |
| Jan 24 2020 | n/a | n/a | US$5b |
| Oct 25 2019 | n/a | n/a | US$5b |
| Jul 26 2019 | n/a | n/a | US$4b |
| Apr 26 2019 | US$4m | US$693k | US$5b |
Compensation vs Market: Geoff's total compensation ($USD20.08M) is above average for companies of similar size in the US market ($USD13.75M).
Compensation vs Earnings: Geoff's compensation has increased by more than 20% in the past year.
CEO
Geoff Martha (55 yo)
Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Independent Directo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 5.3yrs | US$20.08m | 0.0066% $ 7.7m | |
| Executive VP & President of Neuroscience Portfolio | 5.7yrs | US$6.44m | 0.00073% $ 857.2k | |
| Executive Vice President of Enterprise Operations | 4.3yrs | US$7.66m | 0.0015% $ 1.7m | |
| Executive VP & CFO | less than a year | no data | no data | |
| Senior Vice President of Global Operations and Business Services | 8.8yrs | no data | no data | |
| VP, Global Controller & Chief Accounting Officer | less than a year | no data | 0.00031% $ 364.0k | |
| Senior VP of Corporate Finance | less than a year | no data | 0.00062% $ 728.1k | |
| Senior VP and Chief Technology & Innovation Officer | 2.1yrs | no data | no data | |
| Senior VP and Chief Scientific & Medical Officer | 3.3yrs | no data | no data | |
| VP & Head of Investor Relations | 10.1yrs | no data | no data | |
| Executive VP | 3.4yrs | US$11.72m | 0.0021% $ 2.5m | |
| Senior VP & Chief Communications Officer | 4.5yrs | no data | no data |
Experienced Management: MDT's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 5.7yrs | US$20.08m | 0.0066% $ 7.7m | |
| Independent Director | 12.5yrs | US$365.06k | 0.0015% $ 1.8m | |
| Independent Director | 18.5yrs | US$350.06k | 0.0036% $ 4.3m | |
| Independent Director | 10.5yrs | US$385.06k | 0.0035% $ 4.1m | |
| Lead Independent Director | 10.5yrs | US$410.06k | 0.0030% $ 3.5m | |
| Independent Director | 6.3yrs | US$370.06k | 0.00064% $ 751.5k | |
| Independent Director | 11.5yrs | US$370.06k | 0.0012% $ 1.4m | |
| Independent Director | 3.1yrs | US$350.06k | 0.00028% $ 328.8k | |
| Independent Director | 4.8yrs | US$370.06k | 0.00048% $ 563.7k | |
| Independent Director | 2.1yrs | US$306.97k | 0.00013% $ 152.7k | |
| Director | less than a year | no data | no data |
Experienced Board: MDT's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/23 21:34 |
| End of Day Share Price | 2025/07/23 00:00 |
| Earnings | 2025/04/25 |
| Annual Earnings | 2025/04/25 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medtronic plc is covered by 64 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kadambari Daptardar | Accountability Research Corporation |
| Harshit Gupta | Accountability Research Corporation |
| David Toung | Argus Research Company |